National study aims to slash lung infections in preterm babies
NCT ID NCT07109791
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study will look at how often very low birth weight babies in Canadian NICUs get ventilator-associated pneumonia (VAP) and how these infections are treated. Researchers will compare different hospitals' approaches to diagnosis and care, with the goal of creating a shared, evidence-based national guideline. The study involves 1,500 infants and focuses on reducing infections and unnecessary antibiotic use.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to standardized national guidelines that reduce lung infections and unnecessary antibiotic use in fragile newborns.
- What could go wrong
- This is an observational study, not a treatment trial. It collects existing data and may not directly change outcomes. Results depend on hospital cooperation and data quality.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTIBIOTIC-RESISTANT ORGANISMS (AROS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Royal Alexandra Hospital
Edmonton, Alberta, T5H 3V9, Canada
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple blood test flag lung risk in preemies?
- Can a steroid shot into the windpipe protect preemies' lungs?
- Could a simple fat supplement protect preemie lungs?
- Vitamin a shown to protect tiny Preemies' lungs
- Cord blood transfusions could be safer for preterm babies
- Tiny viruses, big impact? study links early gut & lung viruses to preterm lung disease